In the context of biotechnology and financial markets, CGEN is the official NASDAQ and Tel Aviv Stock Exchange ticker symbol for Compugen Ltd., a clinical-stage therapeutic discovery and development company. Scientifically, CGEN represents their proprietary computational discovery platform—a predictive predictive discovery infrastructure leveraging artificial intelligence and machine learning to identify novel drug targets and therapeutic candidates, particularly in the field of cancer immunotherapy.